BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 16799072)

  • 1. Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis.
    Ewer K; Millington KA; Deeks JJ; Alvarez L; Bryant G; Lalvani A
    Am J Respir Crit Care Med; 2006 Oct; 174(7):831-9. PubMed ID: 16799072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decrease in Mycobacterium tuberculosis specific immune responses in patients with untreated psoriasis living in a tuberculosis endemic area.
    Silva LC; Silveira GG; Arnone M; Romiti R; Geluk A; Franken KC; Duarte AJ; Takahashi MD; Benard G
    Arch Dermatol Res; 2010 May; 302(4):255-62. PubMed ID: 19609541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in-house RD1-based enzyme-linked immunospot-gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection.
    Codecasa L; Mantegani P; Galli L; Lazzarin A; Scarpellini P; Fortis C
    J Clin Microbiol; 2006 Jun; 44(6):1944-50. PubMed ID: 16757583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculin skin testing compared with T-cell responses to Mycobacterium tuberculosis-specific and nonspecific antigens for detection of latent infection in persons with recent tuberculosis contact.
    Arend SM; Engelhard AC; Groot G; de Boer K; Andersen P; Ottenhoff TH; van Dissel JT
    Clin Diagn Lab Immunol; 2001 Nov; 8(6):1089-96. PubMed ID: 11687445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Region of difference 1 antigen-specific CD4+ memory T cells correlate with a favorable outcome of tuberculosis.
    Goletti D; Butera O; Bizzoni F; Casetti R; Girardi E; Poccia F
    J Infect Dis; 2006 Oct; 194(7):984-92. PubMed ID: 16960787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly discordant T cell responses in individuals with recent exposure to household tuberculosis.
    Hesseling AC; Mandalakas AM; Kirchner HL; Chegou NN; Marais BJ; Stanley K; Zhu X; Black G; Beyers N; Walzl G
    Thorax; 2009 Oct; 64(10):840-6. PubMed ID: 18682523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot study.
    Vincenti D; Carrara S; Butera O; Bizzoni F; Casetti R; Girardi E; Goletti D
    Clin Exp Immunol; 2007 Oct; 150(1):91-8. PubMed ID: 17680823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells.
    Lalvani A; Pathan AA; Durkan H; Wilkinson KA; Whelan A; Deeks JJ; Reece WH; Latif M; Pasvol G; Hill AV
    Lancet; 2001 Jun; 357(9273):2017-21. PubMed ID: 11438135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country.
    Kang YA; Lee HW; Yoon HI; Cho B; Han SK; Shim YS; Yim JJ
    JAMA; 2005 Jun; 293(22):2756-61. PubMed ID: 15941805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterium tuberculosis epitope-specific interferon-g production in healthy Brazilians reactive and non-reactive to tuberculin skin test.
    Silva BC; Grassi MF; Coutinho R; Mascarenhas RE; Olavarria VN; Coutinho-Borgo A; Kalil J; Cunha Neto E; Fonseca SG
    Mem Inst Oswaldo Cruz; 2014 Dec; 109(8):999-1004. PubMed ID: 25494469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis.
    Diel R; Loddenkemper R; Meywald-Walter K; Niemann S; Nienhaus A
    Am J Respir Crit Care Med; 2008 May; 177(10):1164-70. PubMed ID: 18276940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection.
    Hill PC; Brookes RH; Fox A; Jackson-Sillah D; Jeffries DJ; Lugos MD; Donkor SA; Adetifa IM; de Jong BC; Aiken AM; Adegbola RA; McAdam KP
    PLoS Med; 2007 Jun; 4(6):e192. PubMed ID: 17564487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying recent Mycobacterium tuberculosis transmission in the setting of high HIV and TB burden.
    Mutsvangwa J; Millington KA; Chaka K; Mavhudzi T; Cheung YB; Mason PR; Butterworth AE; Corbett EL; Lalvani A
    Thorax; 2010 Apr; 65(4):315-20. PubMed ID: 20388756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon gamma release assays: principles and practice.
    Lalvani A; Pareek M
    Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):245-52. PubMed ID: 19783328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons.
    Diel R; Nienhaus A; Lange C; Meywald-Walter K; Forssbohm M; Schaberg T
    Respir Res; 2006 May; 7(1):77. PubMed ID: 16707012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific Mycobacterium tuberculosis T cell responses to RD1-selected peptides for the monitoring of anti-tuberculosis therapy.
    Latorre I; Altet N; de Souza-Galvão M; Ruiz-Manzano J; Lacoma A; Prat C; Pérez M; Ausina V; Domínguez J
    Scand J Infect Dis; 2012 Mar; 44(3):161-7. PubMed ID: 21923628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of immunogenic peptides from Mycobacterium tuberculosis genes expressed during macrophage infection.
    Seghrouchni F; Contini S; Markova R; Drenska R; Sadki K; Baassi L; Todorova Y; Terzieva V; Bocchino M; Cappelli G; Altieri AM; Alma MG; Benjouad A; Mariani F; Petrunov B; Colizzi V; El Aouad R; Saltini C; Amicosante M
    Tuberculosis (Edinb); 2009 May; 89(3):210-7. PubMed ID: 19447677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latent tuberculosis infection treatment and T-cell responses to Mycobacterium tuberculosis-specific antigens.
    Chee CB; KhinMar KW; Gan SH; Barkham TM; Pushparani M; Wang YT
    Am J Respir Crit Care Med; 2007 Feb; 175(3):282-7. PubMed ID: 17082492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cells co-producing Mycobacterium tuberculosis-specific type 1 cytokines for the diagnosis of latent tuberculosis.
    Nemeth J; Winkler HM; Karlhofer F; Selenko-Gebauer N; Graninger W; Winkler S
    Eur Cytokine Netw; 2010 Mar; 21(1):34-9. PubMed ID: 20146988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.